These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 828457)

  • 21. Intravenous nitroglycerin: a review.
    Stetson JB
    Int Anesthesiol Clin; 1978; 16(2):261-98. PubMed ID: 99371
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitroglycerin and myocardial ischemia.
    Figueras J; Forrester JS
    Chest; 1978 Jan; 73(1):1-2. PubMed ID: 413694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic range of transdermal nitro-patches].
    Lazebnik LB
    Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return.
    Holtermann W; Lochner W
    Arzneimittelforschung; 1972 Aug; 22(8):1376-81. PubMed ID: 4629177
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model.
    Piek JJ; van Liebergen RA; Koch KT; de Winter RJ; Peters RJ; David GK
    Circulation; 1997 Jul; 96(1):106-15. PubMed ID: 9236424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Criteria of adequate use of nitroglycerin and dopamine in patients with myocardial infarct in relation to the renal state].
    Tikhonov VP; Solomatin VA
    Klin Med (Mosk); 1995; 73(5):75. PubMed ID: 8815295
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intravenous nitroglycerin in the treatment of cardiac insufficiency].
    Carvalho MA; Osterne EC; Carvalho PR; Aloan L; Carneiro RD
    Arq Bras Cardiol; 1977 Apr; 30(2):123-5. PubMed ID: 410392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Informative value of changes in central hemodynamics for the clinical use of various coronary-effective drugs].
    Schneider KW; Jesse R
    Verh Dtsch Ges Inn Med; 1971; 77():976-9. PubMed ID: 5005553
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilators and myocardial infarction.
    Merrill A
    J Med Assoc Ga; 1975 Feb; 64(2):52-4. PubMed ID: 803542
    [No Abstract]   [Full Text] [Related]  

  • 31. Digitalis use in acute myocardial infarction: current concepts.
    Dodek A
    Can Med Assoc J; 1974 Sep; 111(6):561, 563-4. PubMed ID: 4606438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects of the action of nitroglycerin on the hemodynamics of the lesser circulation and heart rhythm disorder in patients with chronic heart failure].
    Kazeĭ DV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):100-1. PubMed ID: 2513837
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
    Kosminskiĭ PG; Vaniev SB; Vasechkin SS; Lazarev IA; Gruzdev AK; Magnitskiĭ AV; Sidorenko BA
    Kardiologiia; 1992 Sep; 32(9-10):15-8. PubMed ID: 1287301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasodilator and inotropic therapy of heart failure [panel discussion].
    Am J Med; 1978 Jul; 65(1):208-16. PubMed ID: 685996
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitroglycerin induces late preconditioning against arrhythmias but not stunning in conscious sheep.
    Lascano EC; Valle HF; Negroni JA
    Scand Cardiovasc J; 2007 Jun; 41(3):160-6. PubMed ID: 17487765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasodilators: treatment of cardiac insufficiency].
    Francoual M; Lellouche D; Castaigne A; Estampes B; Vernant P
    Rev Prat; 1977 Oct; 27(47):3169-79. PubMed ID: 414346
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasodilator therapy for chronic congestive heart failure.
    Abrams J
    JAMA; 1985 Dec; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilator therapy.
    Parmley WW; Chatterjee K
    Curr Probl Cardiol; 1978 Mar; 2(12):23-75. PubMed ID: 348403
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vasodilator therapy in heart failure (author's transl)].
    Kimata S
    Kokyu To Junkan; 1978 Sep; 26(9):863-72. PubMed ID: 100840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.